Abstract
Aspirin as a class I guideline recommended medical treatment for acute coronary syndrome has been established for decades [1]. As early intake of aspirin is crucial, self-administration of aspirin in acute chest pain might be beneficial when weighing up the potential harm including a slightly elevated bleeding risk in patients with chest pain of another origin than myocardial infarction against the benefit in patients with coronary ischemia.
Original language | English |
---|---|
Journal | Wiener Klinische Wochenschrift. The Central European Journal of Medicine |
DOIs | |
Publication status | E-pub ahead of print - 17 Dec 2024 |